170 related articles for article (PubMed ID: 26071584)
1. Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
Kochanowski J; Uchman D; Litwiniuk A; Kalisz M; Wolinska-Witort E; Martynska L; Baranowska B; Bik W
Neuro Endocrinol Lett; 2015; 36(2):148-52. PubMed ID: 26071584
[TBL] [Abstract][Full Text] [Related]
2. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.
Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J
Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Baranowska-Bik A; Kochanowski J; Uchman D; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B; Bik W
J Neuroimmunol; 2013 Oct; 263(1-2):159-61. PubMed ID: 24041830
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
Zusev M; Gozes I
Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
Giladi E; Hill JM; Dresner E; Stack CM; Gozes I
J Mol Neurosci; 2007; 33(3):278-83. PubMed ID: 17952637
[TBL] [Abstract][Full Text] [Related]
7. Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Wens I; Keytsman C; Deckx N; Cools N; Dalgas U; Eijnde BO
Eur J Neurol; 2016 Jun; 23(6):1028-35. PubMed ID: 26992038
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells.
Cellerino A; Arango-González B; Pinzón-Duarte G; Kohler K
J Comp Neurol; 2003 Dec; 467(1):97-104. PubMed ID: 14574682
[TBL] [Abstract][Full Text] [Related]
9. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome.
Nelson PG; Kuddo T; Song EY; Dambrosia JM; Kohler S; Satyanarayana G; Vandunk C; Grether JK; Nelson KB
Int J Dev Neurosci; 2006 Feb; 24(1):73-80. PubMed ID: 16289943
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.
Ciszowski K; Gomółka E; Gawlikowski T; Szpak D; Potoczek A; Boba M
Przegl Lek; 2016; 73(8):552-9. PubMed ID: 29677430
[TBL] [Abstract][Full Text] [Related]
11. Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.
Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Osztynowicz K; Kozubski W; Michalak S
Neurol Neurochir Pol; 2018 Aug; 52(4):483-489. PubMed ID: 29643001
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
Briken S; Rosenkranz SC; Keminer O; Patra S; Ketels G; Heesen C; Hellweg R; Pless O; Schulz KH; Gold SM
J Neuroimmunol; 2016 Oct; 299():53-58. PubMed ID: 27725121
[TBL] [Abstract][Full Text] [Related]
13. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
Bansi J; Bloch W; Gamper U; Kesselring J
Mult Scler; 2013 Apr; 19(5):613-21. PubMed ID: 22936334
[TBL] [Abstract][Full Text] [Related]
14. Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia.
Li XS; Wu HT; Yu Y; Chen GY; Qin XY; Zheng GE; Deng W; Cheng Y
Neurosci Lett; 2018 Nov; 686():28-32. PubMed ID: 30172685
[TBL] [Abstract][Full Text] [Related]
15. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
[TBL] [Abstract][Full Text] [Related]
16. A novel VIP responsive gene. Activity dependent neuroprotective protein.
Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
[TBL] [Abstract][Full Text] [Related]
17. BDNF and Tau as biomarkers of severity in multiple sclerosis.
Islas-Hernandez A; Aguilar-Talamantes HS; Bertado-Cortes B; Mejia-delCastillo GJ; Carrera-Pineda R; Cuevas-Garcia CF; Garcia-delaTorre P
Biomark Med; 2018 Jul; 12(7):717-726. PubMed ID: 29865854
[TBL] [Abstract][Full Text] [Related]
18. Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Mehrpour M; Akhoundi FH; Delgosha M; Keyvani H; Motamed MR; Sheibani B; Meysamie A
Neurologist; 2015 Oct; 20(4):57-60. PubMed ID: 26468869
[TBL] [Abstract][Full Text] [Related]
19. Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them.
Gharzi V; Gangi M; Sayad A; Mazdeh M; Arsang-Jang S; Taheri M
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):548-556. PubMed ID: 30644699
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide can modulate immune and endocrine responses during lipopolysaccharide-induced acute inflammation.
Bik W; Wolinska-Witort E; Chmielowska M; Baranowska-Bik A; Rusiecka-Kuczalek E; Baranowska B
Neuroimmunomodulation; 2004; 11(6):358-64. PubMed ID: 15467350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
